SLC11A2
Natural resistance-associated macrophage protein 2
Also known as: DCT1, DMT-1, DMT1, FLJ37416, NRAM2_HUMAN, NRAMP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49281
- Gene
- SLC11A2
- Ensembl
- ENSG00000110911
- Chromosome
- 12
- Canonical length
- 568 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a member of the solute carrier family 11 protein family. The product of this gene transports divalent metals and is involved in iron absorption. Mutations in this gene are associated with hypochromic microcytic anemia with iron overload. A related solute carrier family 11 protein gene is located on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
568 residues, UniProt reviewed canonical sequence.
>P49281|SLC11A2
1 MVLGPEQKMS DDSVSGDHGE SASLGNINPA YSNPSLSQSP GDSEEYFATY FNEKISIPEE
61 EYSCFSFRKL WAFTGPGFLM SIAYLDPGNI ESDLQSGAVA GFKLLWILLL ATLVGLLLQR
121 LAARLGVVTG LHLAEVCHRQ YPKVPRVILW LMVELAIIGS DMQEVIGSAI AINLLSVGRI
181 PLWGGVLITI ADTFVFLFLD KYGLRKLEAF FGFLITIMAL TFGYEYVTVK PSQSQVLKGM
241 FVPSCSGCRT PQIEQAVGIV GAVIMPHNMY LHSALVKSRQ VNRNNKQEVR EANKYFFIES
301 CIALFVSFII NVFVVSVFAE AFFGKTNEQV VEVCTNTSSP HAGLFPKDNS TLAVDIYKGG
361 VVLGCYFGPA ALYIWAVGIL AAGQSSTMTG TYSGQFVMEG FLNLKWSRFA RVVLTRSIAI
421 IPTLLVAVFQ DVEHLTGMND FLNVLQSLQL PFALIPILTF TSLRPVMSDF ANGLGWRIAG
481 GILVLIICSI NMYFVVVYVR DLGHVALYVV AAVVSVAYLG FVFYLGWQCL IALGMSFLDC
541 GHTCHLGLTA QPELYLLNTM DADSLVSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC11A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 51 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 51 nTPM
- parathyroid gland: 40 nTPM
- thyroid gland: 39 nTPM
- salivary gland: 29 nTPM
- breast: 28 nTPM
- cervix: 28 nTPM
Single-cell type
- renal connecting tubule cells: 153 nCPM
- mast cells: 133 nCPM
- oligodendrocytes: 122 nCPM
- microglia: 121 nCPM
- breast lactating cells: 118 nCPM
- esophageal apical cells: 112 nCPM
Immune cell
- myeloid DC: 7 nTPM
- intermediate monocyte: 6.7 nTPM
- NK-cell: 6 nTPM
- non-classical monocyte: 4.8 nTPM
- classical monocyte: 4.7 nTPM
- naive CD4 T-cell: 4.6 nTPM
Brain region
- white matter: 74 nTPM
- medulla oblongata: 60 nTPM
- pons: 57 nTPM
- basal ganglia: 56 nTPM
- cerebellum: 54 nTPM
- spinal cord: 53 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC11A2.
Disease | AllUniProt
Conditions SLC11A2 is implicated in, by any mechanism.
- Anemia, hypochromic microcytic, with iron overload 1 (AHMIO1) MIM:206100
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 176 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcytic anemia with liver iron overload
- SLC11A2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 2.23
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cadmium ion transmembrane transport
- cellular response to oxidative stress
- cobalt ion transport
- copper ion transport
- dendrite morphogenesis
- detection of oxygen
- erythrocyte development
- heme biosynthetic process
- intracellular iron ion homeostasis
- intracellular manganese ion homeostasis
- iron import into cell
- iron ion transmembrane transport
- iron ion transport
- learning or memory
- manganese ion transport
- multicellular organismal-level iron ion homeostasis
- nickel cation transport
- response to hypoxia
- response to iron ion
- lead ion transport
- vanadium ion transport
Molecular functions
- cadmium ion binding
- cadmium ion transmembrane transporter activity
- cobalt ion transmembrane transporter activity
- copper ion transmembrane transporter activity
- ferrous iron transmembrane transporter activity
- inorganic cation transmembrane transporter activity
- iron ion transmembrane transporter activity
- manganese ion transmembrane transporter activity
- retromer complex binding
- solute:proton symporter activity
- transition metal ion transmembrane transporter activity
- zinc ion transmembrane transporter activity
- lead ion transmembrane transporter activity
- nickel cation transmembrane transporter activity
- vanadium ion transmembrane transporter activity
Cellular components
- apical part of cell
- apical plasma membrane
- basal part of cell
- brush border membrane
- cell surface
- cytoplasm
- cytoplasmic vesicle
- early endosome
- early endosome membrane
- endosome membrane
- extracellular vesicle
- Golgi apparatus
- late endosome
- late endosome membrane
- lysosomal membrane
- lysosome
- membrane
- mitochondrial outer membrane
- mitochondrion
- nucleus
- perinuclear region of cytoplasm
- plasma membrane
- recycling endosome
- recycling endosome membrane
- trans-Golgi network
- vacuole
- paraferritin complex
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC11A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC11A2 as an antibody target. Whether an autoantibody or antibody against SLC11A2 could matter depends on whether native SLC11A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC11A2 is annotated at the cell surface, where native SLC11A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC11A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...